Log In
BCIQ
Print this Print this
 

JHL1227

  Manage Alerts
Collapse Summary General Information
Company JHL Biotech Inc.
DescriptionUndisclosed biosimilar
Molecular Target
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today